Of note, routine measures of complement activity are often poorly reliable in HUS settings, mainly because of the underlying inflammation—which increases C3 and C4 levels—leading to the presence of a dissociated low C3 (versus C4) in only one third of patients with complement-mediated HUS [46,50,63]. The gene discussed is C4A; the disease is hemolytic-uremic syndrome.